The impact of disability on depression among individuals with COPD

Chest

Volumn 137, Issue 4, 2010, Pages 838-845

  Katz, Patricia P ^a,b   Julian, Laura J ^a   Omachi, Theodore A ^a   Gregorich, Steven E ^a   Eisner, Mark D ^a   Yelin, Edward H ^a   Blanc, Paul D ^a,b  

^a Section of Occupational and Environmental Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEPRESSION; DISABILITY; EMPHYSEMA; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 77950808391     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1939     Document Type: Article

References (63)

1. McSweeny A. Quality of life in relation to COPD. In: McSweeny AJ, Grant I, eds. Chronic Obstructive Pulmonary Disease: a Behavioral Perspective. New York, NY: Marcel Dekker, Inc.; 1988:59-85.
2. vanEdeL,YzermansCJ,BrouwerHJ. Prevalenceofdepressioninpatientswithchronicobstructivepulmonarydisease: asystematicreview.Thorax.1999;54(8):688-692.(Pubitemid29341404)
3. van Manen JG, Bindeis PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57(5):412-416. (Pubitemid 34494151)
4. Yohannes AM, Baldwin RC, Connolly MJ. Prevalence of subthreshold depression in elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2003;18(5):412-416. (Pubitemid 36637181)
5. Stage KB, Middelboe T, Stage TB, Sørensen CH, Depression in COPD-management and quality of life considerations. Int J Chron Obstruct Pulmon Dis. 2006;1(3):315-320.
6. van den Bemt: L, Schermer T, Bor H, et al, The risk for depression comorbidity in patients with COPD. Chest. 2009;135(1):108-114.
7. Omachi T, Katz P, Yelin E, et al. Depression and healthrelated quality of life in chronic obstructive pulmonary disease. Am J Med. 2009;122(8):778.e9- e15.
8. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of confronting COPD international survey. Eur Respir J. 2002;20(4):799-805.
9. McSweeny AJ, Grant: I, Heaton RK, Adams KM, Timms RM. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med. 1982;142(3):473-478.
10. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med, 1991;85(suppl B):25-31.
11. LareauSC,Carrieri-KohlmanV,Janson-BjerklieS,RoosPJ. Developmentandtestingofthepulmonaryfunctionalstatusanddyspneaquestionnaire(PF SDQ).Heart.Lung.1994;23(3):242-250.(Pubitemid24175626)
12. LeidyNK,HaaseJE. Functionalperformanceinpeoplewithchronicobstructivepulmonarydisease: aqualitativeanalysis.ANSAdvNursSci.1996;18(3):77-89.(Pubitemid126483862)
13. Leidy NK. Subjective measurement of activity in chronic obstructive pulmonary disease. COPD. 2007;4(3):243-249. (Pubitemid 47345892)
14. LeidyN,KnebelA. Clinicalvalidationofthefunctionalperformanceinventoryinpatientswithchronicobstr uctivepulmonarydisease.RespirCare.1999;44(8):932-939.(Pubitemid29399101)
15. Yohannes AM, Baldwin RC, Connolly Mj. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDBJC screening questionnaire, Int J Geriatr Psychiatric. 2000;15(12):1090-1096.
16. Cicutto L, Brooks D, Henderson K. Self-care issues from the perspective of individuals with chronic obstructive pulmonary disease. Patient Educ Couns. 2004;55(2):168-176. (Pubitemid 39458214)
17. Katz P, Gregorich S, Eisner M, et al. Disability in valued life activities among individuals with COPD and other respiratory conditions. J Cardioresp Rehabil Prev. In press.
18. Bourbeau J. Activities of life: The COPD patient. COPD. 2009;6(3):192-200.
19. Katz PP, Yelin EH. Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol. 1993;20(5):790-796.
20. Kim HF, Kunik ME, Molinari VA, et al. Functional impairment in COPD patients: The impact of anxiety and depression, Psychosomatics. 2000;41(6):465-471.
21. Söderlin MK, Hakala M, Nieminen P. Anxiety and depression in a community-based rheumatoid, arthritis population. Scand J Rheumatol. 2000;29(3):177-183. (Pubitemid 32014432)
22. Bruce ML. Psychosocial risk factors for depressive disorders in late life. Biol Psychiatry. 2002;52(3):175-184.
23. Janssens AC, van Doom PA, de Boer JB, van der Meché FG, Passchier J, Hintzen RQ. Impact: of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand. 2003;108(6):389-395. (Pubitemid 37464117)
24. Cole MG, Dendukuri N. Risk factors for depression among elderly community subjects: a systematic review and metaanalysis. Am J Psychiatry. 2003;160(6):1147-1156. (Pubitemid 41070975)
25. Harris T, Cook DG, Victor C, et al. Predictors of depressive symptoms in older people-a survey of two general practice populations. Age Ageing. 2003;32(5):510-518. (Pubitemid 37220508)
26. Egede LE, Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care, 2004;27(2):421-428.
27. Katz PP, Eisner MD, Yelin EH, et al. Functioning and psychological status among individuals with COPD. Qual Life Res. 2005;14(8):1835-1843.
28. Katz PP, Yelin EH. The development of depressive symptoms among women with rheumatoid arthritis. The role of function. Arthritis Rheum. 1995;38(1):49-56.
29. Katz PP, Yelin EH. Activity loss and the onset of depressive symptoms: do some activities matter more than others? Arthritis Rheum. 2001;44(5):1194-1202.
30. Maurer J, Rebbapragada V, Borson S, et al; ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 suppl):43S-56S.
31. Blanc PD, Eisner MD, Trupin L, Yelin EH, Katz PP, Balmes JR. The association between occupational factors and adverse health outcomes in chronic obstructive pulmonary disease. Occup Environ Med. 2004;61(8):661-667.
32. Katz P, Yelin E, Lubeck D, et al. Satisfaction with function: What type of function do rheumatoid arthritis patients value most? Arthritis Rheum. 2001;44(5):S185.
33. Katz PP, Yelin EH, Eisner MD, Earnest: G, Blanc PD. Performance of valued life activities reflected asthma-specific quality of life more than general physical function. J Clin Epidemiol. 2004;57(3):259-267.
34. Katz P, Morris A, Gregorich S, et al. Valued life activity disability plays a significant role in self-rated health among adults with chronic health conditions. J Clinical Epidemiol. 2009;62(2):158-166.
35. Katz P, Yelin E, Eisner M, et al. Prevalence and psychological impact of disability in valued life activities in COPD and related airways conditions. Paper presented at: The 2005 Annual Meeting of the American Thoracic Society; May 2005; San Diego, CA.
36. Yesavage J, Sheikh J. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1-2):165-173.
37. Ferraro FR, Chelminski I. Preliminary normative data on the Geriatric Depression Scale-Short Form (GDS-SF) in a young adult sample. J Clin Psychol. 1996;52(4):443-447. (Pubitemid 26256231)
38. Mancuso CA, Peterson MG, Charlson ME, Effects of depressive symptoms on health-related quality of life in asthma patients. J Gen Intern Med. 2000;15(5):301-310. (Pubitemid 30333827)
39. Zalsman G, Weizman A, Carel CA, Aizenberg D. Geriatric Depression Scale (GDS-15): a sensitive and convenient; instrument for measuring depression in young anorexic patients. J Nero Ment Dis. 2001;189(5):338-339.
40. Weintraub D, Saboe K, Stern MB. Effect of age on geriatric depression scale performance in Parkinson's disease. Mov Disord. 2007;22(9):1331-1335. (Pubitemid 47325045)
41. Mancuso CA, Westermann H, Choi TN, Wenderoth S, Briggs WM, Charlson ME. Psychological and somatic symptoms in screening for depression in asthma patients. J Asthma. 2008;45(3):221-225. (Pubitemid 351549804)
42. McDowell I. Measuring Health: a Guide To Rating Scales and Questionnaires. 3rd ed. New York, NY: Oxford University Press; 2006.
43. Julian L, Gregorich S, Earnest G, et al. Screening for depression in chronic obstructive pulmonary disease. J Chron Obstruct Pulmon Dis. In press.
44. Chopra MP, Zubritsky C, Knott: K, et al. Importance of subsyndromal symptoms of depression in elderly patients. Am J Geriatr Psychiatry. 2005;13(7):597-606.
45. Eisner MD, Trupin L, Katz PP, et al, Development and validation of a survey-based COPD severity score. Chest. 2005;127(6):1890-1897.
46. Omachi TA, Yelin EH, Katz PP, Blanc PD, Eisner MD. The COPD severity score: a dynamic prediction tool for healthcare utilization. COFD. 2008;5(6):339-346.
47. Miravitlles M, Llor C, de Castellar R, Izquierdo I, Baró E, Donado E. Validation of the COPD severity score for use in primary care: The NEREA study. Eur Respir J. 2009;33(3):519-527.
48. Norman G, Sloan J, Wyrwich K. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care. 2003;41(5):582-592.
49. Make B. How can we assess outcomes of clinical trials: The MCID approach. COPD. 2007;4(3):191-194.
50. Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205-1211.
51. Kempen G, Steverink N, Ormel J, et al. The assessment of ADL among frail elderly in an interview survey: self-report versus performance-based tests and determinants of discrepancies. J Gerontol B Psychol Sci Soc Sci. 1996;51(5):P254-P260.
52. Almagro P, Caibo E, Oclioa de Echagüen A, et al. Mortality after hospitalization for COPD. Chest. 2002;121(5):1441-1448.
53. Dowson CA, Town GI, Frampton C, Mulder RT, Psychopathology and illness beliefs influence COPD self-management. J Psychosom Res. 2004;56(3):333-340.
54. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007; 167(1):60-67.
55. Xu W, Collet JP, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit. Care Med. 2008;178(9):913-920.
56. de Voogd. JN, Wempe JB, Koëter GH, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009;135(3):619-625.
57. Ng TP, Niti M, Fones C, Yap KB, Tan WC. Co-morbid association of depression and COPD: a population-based study. Respir Med. 2009;103(6):895-901.
58. Penninx BW, Guralnik JM, Ferruca L, Simonsick EM, Deeg DJ, Wallace RB. Depressive symptoms and physical decline in community-dwelling older persons. JAMA. 1998;279(21):1720-1726.
59. Covinsky KE, Kahana E, Chin MH, Palmer RM, Fortinsky RH, Landefeld CS. Depressive symptoms and 3-year mortality in older hospitalized medical patients. Ann Intern Med. 1999;130(7):563-569.
60. van Gool CH, Kempen GI, Penninx BW, Deeg DJ, Beekman AT, van Eijk JT, Impact of depression on disablement in late middle aged and older persons: results from the Longitudinal Aging Study Amsterdam. Soc Sci Med. 2005;60(1):25-36.
61. Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R. Anxiety, depression, and cause-specific mortality: The HUNT study. Psychosom Med. 2007;69(4):323-331.
62. Güell R, Resqueti V, Sangenis M, et al. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest. 2006;129(4):899-904.
63. Warden D, Rush AJ, Wisniewski SR, et al. What predicts attrition in second step medication treatments for depression? A STAR* D Report, Int J Neuropsychopharmacol. 2009;12(4):459-473.